Rare Disease
RARE & INHERITED DISORDERS | Long-Read Genomics for Precision Diagnosis
Rare and inherited disorders represent a complex and often underdiagnosed spectrum of diseases driven by diverse genetic mechanisms. At Nucleome, we decode this complexity through high-resolution, long-read genomics and integrated multi-omics approaches, enabling comprehensive detection of variants that are frequently missed by conventional methods. From structural variants and repeat expansions to non-coding and regulatory alterations, we provide a complete view of the genetic architecture underlying disease.
Our approach bridges unresolved clinical cases with advanced genomic technologies, enabling accurate diagnosis, novel gene discovery, and deeper understanding of disease biology. By integrating sequencing with robust bioinformatics and phenotype-driven interpretation, we transform fragmented genetic signals into clinically actionable insights for inherited and rare disorders. Partner with Nucleome to unlock the full spectrum of genetic variation—driving precision diagnostics and accelerating breakthroughs in rare disease research and care.
“In rare and inherited diseases, the answer is often hidden in genomic complexity—only resolved when the genome is read in its full continuity.”
Why Rare & Inherited Disease Genomics Matters
- Enables detection of complex genetic variants including structural variants, repeat expansions, and non-coding mutations often missed by standard approaches.
- Improves diagnostic yield in previously unresolved or undiagnosed clinical cases.
- Supports identification of de novo mutations and inherited pathogenic variants through family-based analysis.
- Provides insights into genotype–phenotype relationships, enabling accurate disease characterization.
- Accelerates novel gene discovery and understanding of rare disease biology.
- Facilitates precision medicine approaches, including targeted therapies and personalized clinical management.
Next-Generation Sequencing Ecosystem for Rare & Inherited Disease Genomics
At Nucleome, our rare and inherited disease genomics ecosystem integrates advanced sequencing strategies to enable comprehensive detection of genetic variation across the genome. We combine long-read and short-read sequencing platforms to capture both coding and non-coding regions, enabling identification of single nucleotide variants (SNVs), indels, copy number variations (CNVs), structural variants (SVs), and repeat expansions.
Our infrastructure includes high-throughput and high-fidelity sequencing systems such as PacBio HiFi long-read platforms (e.g., Revio, Sequel II), Oxford Nanopore Technologies (ONT), Illumina NovaSeq series, Ion Torrent platforms, and microarray-based genotyping systems, enabling flexible and scalable genomic analysis across diverse applications.
Bioinformatics Analysis & Interpretation
At Nucleome, we implement advanced, clinically oriented bioinformatics pipelines to transform sequencing data into high-confidence, actionable insights for rare and inherited disorders. Our workflows encompass data preprocessing, alignment, variant calling, and multi-layered annotation, ensuring comprehensive detection of SNVs, indels, CNVs, structural variants, and repeat expansions.
Our pipelines further support structural variant interpretation, repeat expansion analysis, and non-coding variant annotation, enabling resolution of complex genomic regions often implicated in rare diseases. Clinical interpretation follows established guidelines (e.g., ACMG/AMP frameworks) to ensure robust, reproducible, and clinically relevant classification of variants.
By integrating genomic data with clinical and phenotypic metadata, we deliver comprehensive diagnostic reports, novel variant discovery, and precision insights, bridging the gap between genomic data and real-world clinical decision-making.
Our Key Solutions
Whole Genome Long-Read Sequencing
High-fidelity, long-read whole genome sequencing enabling contiguous genome assembly and comprehensive detection of coding and non-coding variants, including complex genomic regions.
Resolves previously inaccessible regions and complex variants, significantly improving diagnostic yield in unresolved and rare disease cases.
Structural Variant & CNV Analysis
Genome-wide detection and characterization of structural variants (SVs) and copy number variations (CNVs), including insertions, deletions, duplications, and inversions.
Best suited for: Captures large-scale genomic alterations that are often missed by conventional sequencing, critical for accurate disease diagnosis.
Repeat Expansion & Complex Region Analysis
Targeted analysis of repeat expansions and highly repetitive genomic regions, including tandem repeats and low-complexity sequences.
Best suited for: Essential for identifying repeat expansion disorders and variants in difficult-to-map regions, a major cause of neurological and inherited diseases.
Full-Length Transcriptome (Isoform-Level) Analysis
Sequencing of full-length transcripts to resolve isoform diversity, alternative splicing events, and transcript structure at high resolution.
Best suited for: Provides functional insights into gene expression and splicing alterations, improving interpretation of disease-associated variants.
Variant Prioritization & Clinical Interpretation
Comprehensive annotation, filtering, and prioritization of variants using clinical databases, phenotype correlation, and pathogenicity frameworks.
Why it should be done: Transforms raw genomic data into clinically actionable insights, enabling precise diagnosis and informed treatment decisions.